Group 1 - The circuit board index experienced a strong rally, with constituent stocks showing a broad upward trend [1] - Shiyun Circuit led the gains, followed by Mingyang Circuit, Pengding Holdings, Guanghe Technology, and Xingsen Technology, which all had significant increases [1]

证券代码：300648 证券简称：星云股份 公告编号：2026-005 福建星云电子股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 产品发行 主体 产品名称 产品类型 认购 金额 起息日 到期日 预计年 化收益 率 赎回 本金 到期 收益 兴业银行 7 天通知存款 固定收益 型 1,000 万元 2025 年 6 月 5 日 2026 年 1 月 29 日 0.75% 1,000 万元 4.98 万元 一、公司使用部分闲置募集资金购买理财产品部分到期赎回的情况 二、本公告日前十二个月公司累计使用闲置募集资金进行现金管理的情况 | 序号 | 产品发 | 产品名称 | 产品 | 购买 | 起息日 | | 到期日 | 是否 | 理财 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 行主体 | | 类型 | 金额 | | | | 赎回 | 收益 | | 1 | 招商银行 | 招商银行点金系列 看涨两层区间 273 天 ...

此外，星云股份方面表示，公司对外投资的参股公司2025年确认的投资亏损较上年同期有所扩大，对当 期损益造成一定拖累；公司基于会计政策及谨慎性原则，对部分长库龄及存在减值迹象的存货等资产计 提了减值准备。#星云股份 sz300648[股票]# 中经记者 庄灵辉 深圳报道 【业务转型影响 #星云股份预计2025年度亏损扩大#】2026年1月29日晚间，星云股份（300648.SZ）发 布2025年度业绩预告。根据公告信息，星云股份预计2025年度归母净利润亏损1.55亿元至2.3亿元，上年 同期亏损8244.88万元；扣非净利润预计亏损1.7亿元至2.48亿元，上年同期亏损9744.78万元。 星云股份方面将2025年度亏损解释为当期费用投入增加及业务转型影响。 "2025年度，市场竞争激烈，为保持长期核心竞争力，公司加大新技术、新产品研发投入及海内外市场 渠道建设力度，叠加人工成本同比上升，全年销售费用、管理费用及研发费用等期间费用规模同比增 加。"星云股份方面表示，公司仍处于以锂电设备业务为基础、拓展规模化产品的转型阶段，储能及快 充产品尚未形成较高规模收入。 ...

Core Viewpoint - Xingyun Co., Ltd. (300648.SZ) anticipates a significant increase in losses for the fiscal year 2025, projecting a net loss attributable to shareholders between 155 million to 230 million yuan, compared to a loss of 82.44 million yuan in the previous year [2] Financial Performance - The expected net loss for 2025 is between 155 million to 230 million yuan, while the expected non-recurring net loss is projected to be between 170 million to 248 million yuan, compared to a loss of 97.44 million yuan in the previous year [2] Business Transformation - The company attributes the anticipated losses to increased expenses and the impact of business transformation, emphasizing the need for investment in new technologies and products to maintain long-term competitiveness [2] Market Conditions - The company notes that the market is highly competitive in 2025, leading to increased investments in research and development, as well as in domestic and international market channel development [2] Cost Structure - There has been a year-on-year increase in sales, management, and research and development expenses, driven by rising labor costs [2] Investment Losses - The company has reported that investment losses from its equity investees for 2025 are expected to widen compared to the previous year, contributing to the overall financial strain [2] Asset Impairment - Based on accounting policies and a principle of prudence, the company has made provisions for impairment on certain long-held and potentially impaired inventory and other assets [2]

Earnings Forecasts - Shengyi Electronics expects a net profit of 1.431 billion to 1.513 billion yuan in 2025, an increase of 331.03% to 355.88% year-on-year [1] - Tigermed anticipates a net profit of 830 million to 1.23 billion yuan in 2025, representing a growth of 105% to 204% year-on-year [2] - Shunbo Alloy forecasts a net profit of 210 million to 270 million yuan in 2025, with an increase of 222.96% to 315.23% year-on-year [3] - Jinkong Electric expects a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% year-on-year [9] - Baiao Saitu anticipates a net profit of 162 million to 182 million yuan in 2025, with a year-on-year increase of 384.26% to 443.88% [18] - Panjiang Co. expects a net profit of 318 million to 380 million yuan in 2025, representing a growth of 205.30% to 264.83% year-on-year [38] Loss Forecasts - Liaoning Energy predicts a net loss of 273 million to 410 million yuan in 2025, compared to a profit of 202 million yuan in the previous year [5] - Anbotong anticipates a net loss of 114 million to 165 million yuan in 2025, with a revenue decrease of 19.65% to 27.25% [7] - Wantai Bio forecasts a net loss of 330 million to 410 million yuan in 2025, compared to a profit of 106 million yuan in the previous year [12] - Xingyun Co. expects a net loss of 155 million to 230 million yuan in 2025, compared to a loss of 82.44 million yuan in the previous year [20] - Huaxing Co. anticipates a net loss of 800 million to 1.2 billion yuan in 2025, with a reduction in loss compared to 1.67 billion yuan in the previous year [46] New Product Approvals - Hengrui Medicine received acceptance for a new indication application for its innovative drug, combining Carrelizumab and Apatinib for treating unresectable liver cancer [4] - Tianen Kang's subsidiary received a drug registration acceptance notice for Lidocaine and Prilocaine aerosol [31] - Lisheng Pharmaceutical announced that its Aminophylline tablets passed the consistency evaluation for generic drugs [40] Share Buyback Plans - Hengyuan Coal Power plans to repurchase shares with a total amount not less than 200 million yuan and not exceeding 250 million yuan [13] Contract Wins - China Communication Signal Co. won contracts totaling approximately 5.26 billion yuan for 21 important projects in the railway and urban rail transit markets [37]

格隆汇1月29日丨星云股份(300648.SZ)公布，预计2025年亏损15,500万元—23,000万元，上年同期亏损 8,244.88万元；扣非亏损17,000万元—24,800万元。2025年度，市场竞争激烈，为保持长期核心竞争力， 公司加大新技术、新产品研发投入及海内外市场渠道建设力度，叠加人工成本同比上升，全年销售费 用、管理费用及研发费用等期间费用规模同比增加。同时，公司仍处于以锂电设备业务为基础、拓展规 模化产品的转型阶段，储能及快充产品尚未形成较高规模收入。 ...

智通财经APP讯，星云股份(300648.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净亏损 1.55亿元至2.3亿元;扣除非经常性损益后的净亏损1.7亿元至2.48亿元。 ...

星云股份（300648）(300648.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净亏损1.55亿 元至2.3亿元;扣除非经常性损益后的净亏损1.7亿元至2.48亿元。 ...

Core Viewpoint - The company, Xingyun Co., Ltd., is forecasting a significant net loss for the year 2025, with expected losses ranging from 155 million to 230 million yuan for net profit attributable to shareholders, and from 170 million to 248 million yuan for net profit after deducting non-recurring gains and losses [1]. Summary by Categories Financial Performance - The company anticipates a net loss of 155 million to 230 million yuan for 2025, with a net loss of 170 million to 248 million yuan when excluding non-recurring items [1]. - Non-recurring gains and losses are expected to impact the net profit attributable to shareholders by approximately 22 million yuan [1]. Reasons for Performance Change - Increased expenses and business transformation are primary reasons for the anticipated losses, including heightened investment in new technologies and products, as well as rising labor costs [1]. - The company is in a transitional phase, focusing on expanding its lithium battery equipment business, with energy storage and fast-charging products not yet generating significant revenue [1]. - Investment losses from associated companies have increased compared to the previous year, contributing to the overall financial strain [1]. - The company has made provisions for asset impairment based on accounting policies, affecting the financial results [1]. Future Outlook - Despite the losses, the company aims to maintain its core technological advantages in battery testing and power electronics, with ongoing improvements in cash flow from operating activities [1]. - The company plans to promote its energy storage system products and will focus on enhancing revenue through various initiatives in 2026, including project construction and cost control measures [1].

证券代码：300648 证券简称：星云股份 公告编号：2026-004 福建星云电子股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日 2、业绩预告情况：预计净利润为负值 | 项 | 目 | 本报告期 | | | 上年同期 | | | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司股 东的净利润 | | 亏损：15,500 | 万元—23,000 | 万元 | 亏损：8,244.88 | 万元 | | 扣除非经常性损益 后的净利润 | | 亏损：17,000 | 万元—24,800 | 万元 | 亏损：9,744.78 | 万元 | （二）报告期内，预计公司非经常性损益对归属于上市公司股东的净利润的 影响金额约为 2,200 万元，具体数据以公司 2025 年年度报告最终披露的财务数 据为准。 二、与会计师事务所沟通情况 本次业绩预告相关的财务数据未经注册会计师审计。 ...